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IMMARY OR PRINCIPAL FINDINGS AND THEIR SIGNIFICANCE (State succinctly in language understandable to one not neces-
rily expert in this field. Include exten t to whi ch original goals have been realized and any changes to original plan made or 
nt :emplated.) 
matrypsin and elastase are members of a family of protein cleaving enzymes called serine 
'teases. These enzymes are among the most widely studied in terms of their structure and 
chanism of action. We intially set out to study via x-ray crystallography the binding of 
111 molecules such as inhibitors or substrates to these enzymes. Subsequently, various 
nbers of the serine protease family were implicated in several diseases. In particular, 
Lmonary emphysema is currently thought to result from the uninhibited proteolysis of lung 
3sue by elastase and related neutral proteases derived from leukocytes and macrophages. 
Is, we shifted the major .thrust of our research to a study of the extended substrate 
"ding site of serine proteases. The knowledge gained was then applied in the design of 
:y reactive and specific active site inhibitors. 
astase. A few years ago, it appeared to us that peptide chloromethyl ketones were likely 
id.idates for use as elastase inhibitors. We synthesized a series of five tripeptide and 
it tetrapeptide chloromethyl ketones and studies their rates of inactivation of porcine 
icreatic elastase. Most of the compounds were effective inhibitors and were specific 
'ice the related serine proteases chymotrypsin and trypsin were not significantly in-
Dited by the peptide chloromethyl ketones under identical reaction conditions. 
Our next goal was a study of the inhibition of human leukocyte elastase, the enzyme 
Leh is probably the destructive agent in emphysema. This was accomplished using enzyme 
Lciously supplied by Aaron Janoff (Stoney Brook, N.Y). The results indicated that leukocyte 
istase reacts less rapidly overall with this group of peptide chloromethyl ketones than 
s porcine pancreatic elastase. The most effective inhibitor for both the human leukocyte 
porcine pancreatic elastase in this series of compounds is Ac-Ala-Ala-Pro-AlaCH2C1. 
Peptide Carbazates. In a search for inhibitors of elastase which were not alkylating 
mts such as chloromethyl ketones, we have investigated peptide carbazates. Carbazates 
h the appropriate substituent are analogs of amino acids in which the a-methine group has 
al replaced by a nitrogen atom. We synthesized Ac-Ala-Bzc-ONp(Bzc=NHN(CH 2C6H5)C0-), 
itrophenyl) and found that it acylated chymotrypsin to yield a stable derivative. Elastase 
not react, but did react with the methyl carbazate Ac-Ala-Ala-Mec-ONp(Mec=NHN(CH3)C0-). 
se results are in accord with the substrate specificity of these two enzymes. Ac-Ala-Ala- 
-0Np is turning into a very interesting reagent since it can be used to carry out an active 
e titration of porcine elastase and human leukocyte elastase, since the release of 
itrophenol is stochiometric. 
Significance. Synthetic elastase inhibitors have proven to be useful reagents for the 
dy of the biologic function of elastolytic enzymes. In the past two years we have supplied 
pies of the chloromethyl ketones Ac-Ala-Ala-Pro-AlaCH 2C1 and Ac-Ala-Ala-Ala-AlaCH2C1 to 
r 35 other principal investigators in this and other countries for in vivo and in vitro  
dies with human leukocyte enzymes. At present, half a dozen papers have appeared in which 
se compounds have been utilized. Peptide carbazates, being of more recent origin, have 
s far only been requested by 13 other principal investigators. It is my belief that these 
pounds or related ones will eventually be used in the treatment of emphysema and similar 
eases. 
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iTUDENT PARTICIPATION (Give names of students working on the project, their role in the research, their achievements and 
heir career plans.) Barry Chelm, B. Lee Baker, Janice Brown, Philip Andrews and Mark Lively 
tre undergraduates who did research working in my group at various times during the past few 
Lars. The results of the first three are published in a paper in JACS (ref. below). Janice 
!own is currently finishing her PhD at U. of Illinois in biochemistry, Barry Chelm is at the 
of Colorado in biochemistry, B. Lee Baker is in Medical School, Philip Andrews is in 
7aduate school at Purdue and Mark Lively is a graduate student at Georgia Tech. Peter Tuhy 
id Ron Whitley received their PhD's last year from Georgia Tech and are currently doing post-
Lctorial research at Brookhaven National Labs and the Mayo Clinic. Peter's results have been 
'Wished (refs. below). Dave Carroll didn't complete his PhD and is currently employed at 
agate. However, his research resulted in several publications. Dave Rasnick is currently 
graduate student at Georgia Tech. All of the students made substantial contributions to 
to research as the publications (past and future) indicate. With the exception of Mr. Baker, 
J. are pursuing careers in biochemistry. 
'APERS AND SCIENTIFIC TALKS (Give titles and references to papers or talks resulting from the work. Attach two copies of 
my reprints available, if not previously forwarded.) 
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Introduction. Chymotrypsin and elastase are members of a family of protein 
cleaving enzymes called serine proteases. These enzymes are among the most 
widely studied in terms of their structure and mechanism of action. Recently 
various members of the serine protease family have been implicated in several 
diseases. In particular, pulmonary emphysema is currently thought to result 
from the uninhibited proteolysis of lung tissue by elastase and related neutral 
proteases derived from leukocytes and macrophages. The major thrust of our 
research has been a study of the extended substrate binding site of serine 
proteases. The knowledge gained is then applied in the design of very reactive 
and specific active site inhibitors. Synthetic elastase inhibitors in particu-
lar would be expected to be useful reagents both for the treatment of emphy-
sema and related diseases and for the study of the biological function of 
elastolytic enzymes. 
Chymotrypsin Subsite Binding Free Energies. A series of N-acyl and 
N-peptidyl-2-phenylethylamines was synthesized in order to measure subsite 
binding free energies. These substrate analogs are expected to bind to 
chymotrypsin's extended substrate binding site in much the same manner as 
a normal peptide substrate. The dissociation constants of complexes of 
chymotrypsin with various acyl phenyl ethylamines were measured and the free 
energies calculated. The free energies of binding became more negative with 
increasing number of interactions as predicted from a crystallographic model. 
The major contributors to the binding free energy were the interaction of the 
phenylethyl side chain of inhibitors with a hydrophobic pocket on the enzyme 
surface and other hydrophobic interactions. Comparison of the data in the 
literature provides support for the hypothesis that serine proteases place 
the scissionable peptide bond of a substrate on a stereoelectronic "rack" 
favoring formation of a tetrahedral intermediate. 
Elastase. A few years ago, it appeared to us that peptide chloromethyl 
ketones were likely candidates for use as elastase inhibitors. The crystal-
lographic determinations of the binding modes of peptide chloromethyl ketones 
to chymotrypsin and subtilisin had provided insights into the interactions 
of inhibitors with these serine proteases. The inhibitors were covalently 
bound to imidazole ring of the active site hiotidine residue and the extended 
peptide chain of the inhibitor formed a 13-sheet structure with a three residue 
section of the enzyme's backbone. We synthesized a series of five tripeptide 
and four tetrapeptide chloromethyl ketones and studied their rates of in-
activation of porcine pancreatic elastase. Most of the compounds were 
effective inhibitors with Ac-Ala-Ala-Pro-AlaCH2C1 being the most reactive. 
The inhibitors were specific 
AlaCH2C1 = 	NHCHCOCH2C1 
CH3 
since the related serine proteases chymotrypsin and trypsin were not signifi-
cantly inhibited by the peptide chloromethyl ketones under identical reaction 
conditions. 
Our next goal was a study of the inhibition of human leukocyte elastase, 
the enzyme which is probably the destructive agent in emphysema. This was 
accomplished using enzyme graciously supplied by Aaron Janoff (Stoney Brook, 
N.Y.). The results indicated that leukocyte elastase reacts less rapidly 
overall with this group of peptide chloromethyl ketones than does porcine 
pancreatic elastase. The most effective inhibitor for both the human leuko-
cyte and porcine pancreatic elastase in this series of compounds is 
Ac-Ala-Ala-Pro-A1aCH2C1. Interestingly, its isomer Ac-Ala-Pro-Ala-AlaCH2C1 
is a relatively good inhibitor for the leukocyte enzyme, but is not effective 
toward the pancreatic enzyme, which is strong evidence that the pancreatic 
and leukocyte enzymes are distinct entities. More recently, we have discovered 
that Ac-Ala-Ala-Pro-Val-CH2C1 is more effective than the alanine compound at 
inhibiting the human leukocyte enzyme. 
Peptide Carbazates. In a search for inhibitors of elastase which were 
not alkylating agents such as chloromethyl ketones, we have investigated 
peptide carbazates. Carbazates with the appropriate substituent are analogs 
of amino acids in which the a-methine group has been replaced by a nitrogen 
atom. These would be expected to acylate a serine protease with the approp-
riate specificity in much the same fashion as simple synthetic peptide sub-
strate. The acylated enzymes should be considerably more stable toward 
deacylation than a normal "acyl enzyme" due to the influence of the adjacent 
nitrogen atom. We synthesized Ac-Ala-Bzc-ONp (Bzc =-NHN(CH2C6H5)C0-, 
.Np = pL.nitrophenylyand found that it acylated chymotrypsin to yield a stable 
derivative. Elastase did not react, bUt did react with the methyl carbazate 
Ac-Ala-Ala-Mec-ONp (Mec =-NHN(CH3 )C0-). Theses results are in accord with 
the substrate specificity of these two enzymes. Ac-Ala-Ala-Mec-ONp is turn-
ing into a very interesting reagent since it can be used to carry out an 
active site titration of porcine elastase and human leukocyte elastase, since 
the release of p-nitrophenol is stochiometric. 
Significance. It is likely that synthetic elastase inhibitors will be 
useful reagents for the treatment of emphysema and related diseases are for 
the study of the biologic function of elastolytic enzymes. 
In the past two years we have supplied samples of the chloromethyl ketones 
Ac-Ala-Ala-Pro-AlaCH 2C1 and Ac-Ala-Ala-Ala-AlaCH2C1 to over 35 other principal 
investigators in this and other countries for in vivo and in vitro studies 
with human leukocyte enzymes. 
-4- 
At present half a dozen papers have appeared in which these compounds have been 
utilized. Peptide carbazates, being of more recent origin, have thus far only 
been requested by three other principal investigators. It is my belief that 
these compounds or related ones will eventually be used in the treatment of 
emphysema and similar diseases. 
